The Implementation of a Pretomanid-Based Treatment Regimen for Multidrug-Resistant Tuberculosis: A Case Series

Dtsch Arztebl Int. 2023 Sep 22;120(38):641-642. doi: 10.3238/arztebl.m2023.0172.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Nitroimidazoles*
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • pretomanid
  • Antitubercular Agents
  • Nitroimidazoles